A comparative evaluation of bioequivalence of Gan & Lee glargine U300 and Toujeo® in Chinese healthy male participants

BackgroundTo assess the bioequivalence between Gan & Lee (GL) glargine U300 and Toujeo® regarding pharmacokinetics (PK), pharmacodynamics (PD), and safety in Chinese healthy male participants.MethodsA single-center, randomized, double-blind, single-dose, two-preparation, two-sequence, four-cycle...

Полное описание

Библиографические подробности

Главные авторы:	Xiaoli Li, Anshun He, Bingyan Liu, Rongfang Shan, Juan Zhu, Xiaoyue Li, Tian Xie, Yue Li, Mengmeng Chen, He Su, Chaoyang Zhang, Lufeng Li, Dongmei Cheng, Juan Chen, Ying Wang, Yue Su, Yuanyuan Xu, Zhuoran Li, Huan Zhou, Wei Chen, Yuanyuan Liu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2024-08-01
Серии:	Frontiers in Endocrinology
Предметы:	diabetes insulin glargine U300 bioequivalence biosimilar pharmacokinetics pharmacodynamics
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1407829/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!